AnaptysBio's GAAP loss for 3 months of 2022 was $36.255 million, up 99.6% from $18.163 million in the prior year. Revenue decreased 11.59 times to $0.97 million from $11.247 million a year earlier.
AnaptysBio's GAAP loss for 3 months of 2022 was $36.255 million, up 99.6% from $18.163 million in the prior year. Revenue decreased 11.59 times to $0.97 million from $11.247 million a year earlier. 
ir.anaptysbio.com
English (US) 